Successful Treatment of Cheilitis Glandularis Accompanied by Pseudomonas aeruginosa Infection: A Case Report
Abstract
Cheilitis glandularis (CG) is a rare inflammatory disorder affecting the minor salivary glands. Nonetheless, the ideal management of CG remains elusive. Hence, this study aimed to broaden the understanding of the etiopathogenesis of CG and recommend bacterial culture and drug sensitivity tests for CG patients with suspected infection.
A 78-year-old female came to our hospital complaining of painful protrusion in her right lower labial mucosa for three weeks. Clinical examination revealed local enlargement with pyorrhea on the right lower labial mucosa. Histopathological examination indicated the features of CG. Bacterial culture and drug sensitivity test demonstrated Pseudomonas aeruginosa (P. aeruginosa) infection with several susceptible antibiotics. The patient was treated with surgical excision of the right lower labial mucosa combined with levofloxacin daily for two weeks. At the 4-week follow-up after excision, only a small amount of scar remained in the excision area. The patient had no symptoms in the oral mucosa.
CG may be accompanied by P. aeruginosa infection. Bacterial culture and drug sensitivity tests may contribute to identifying potential pathogens in CG patients and improving the efficacy of the treatment.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.